Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Other Operating Expenses (2019 - 2023)

Profound Medical has reported Other Operating Expenses over the past 5 years, most recently at -$6.5 million for Q4 2023.

  • For Q4 2023, Other Operating Expenses fell 255.72% year-over-year to -$6.5 million; the TTM value through Sep 2024 reached -$6.5 million, down 160.89%, while the annual FY2022 figure was $11.0 million, 43.65% up from the prior year.
  • Other Operating Expenses for Q4 2023 was -$6.5 million at Profound Medical, down from $2.2 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $4.2 million in Q4 2022 and troughed at -$6.5 million in Q4 2023.
  • A 5-year average of $1.3 million and a median of $1.7 million in 2021 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: soared 334.99% in 2020 and later tumbled 255.72% in 2023.
  • Year by year, Other Operating Expenses stood at $976957.0 in 2019, then rose by 21.36% to $1.2 million in 2020, then surged by 94.24% to $2.3 million in 2021, then soared by 82.28% to $4.2 million in 2022, then tumbled by 255.72% to -$6.5 million in 2023.
  • Business Quant data shows Other Operating Expenses for PROF at -$6.5 million in Q4 2023, $2.2 million in Q3 2023, and $2.3 million in Q2 2023.